These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8156319)

  • 1. Acetylator phenotypes in primary Sjögren's syndrome.
    Rantapää Dahlqvist S; Mjörndal T; Ostberg Y
    Br J Rheumatol; 1994 Apr; 33(4):405-6. PubMed ID: 8156319
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomic diagnosis of Sjögren's syndrome.
    Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
    Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oligophrenia combined with congenital cataracts. Contribution to the metabolic anomaly of Sjögren's syndrome].
    Engels HJ
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):91-106. PubMed ID: 5968200
    [No Abstract]   [Full Text] [Related]  

  • 4. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
    Kabeerdoss J; Sandhya P; Danda D
    Int J Rheum Dis; 2017 Nov; 20(11):1763-1766. PubMed ID: 29152879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation leads to lower FOXP3 expression in CD4+ T cells of patients with primary Sjögren's syndrome.
    Yu X; Liang G; Yin H; Ngalamika O; Li F; Zhao M; Lu Q
    Clin Immunol; 2013 Aug; 148(2):254-7. PubMed ID: 23773924
    [No Abstract]   [Full Text] [Related]  

  • 6. Sjögren's syndrome. Additional diagnostic tools.
    Abramson AL; Goodman M; Kolodny H
    Arch Otolaryngol; 1968 Jul; 88(1):91-4. PubMed ID: 5660033
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value of salivary beta 2 microglobulin concentration for diagnosis of Sjögren's syndrome].
    Du D; Pu Y; Zhao Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):72-4. PubMed ID: 10453557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome.
    Baldini C; Gallo A; Perez P; Mosca M; Alevizos I; Bombardieri S
    Clin Exp Rheumatol; 2012; 30(5):785-90. PubMed ID: 23009763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Sjögren's syndrome in monozygotic twins.
    Lee WS; Yoo WH
    Int J Rheum Dis; 2014 Jun; 17(5):578-9. PubMed ID: 24863905
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.
    Kay RA; Hay EM; Holt PJ; Bernstein RM; Ollier WE
    Br J Rheumatol; 1994 Feb; 33(2):193-4. PubMed ID: 8162491
    [No Abstract]   [Full Text] [Related]  

  • 12. Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis.
    Shen L; He J; Kramer JM; Bunya VY
    J Immunol Res; 2019; 2019():8101503. PubMed ID: 31236421
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.
    Sisto M; Lorusso L; Ingravallo G; Nico B; Ribatti D; Ruggieri S; Lofrumento DD; Lisi S
    Autoimmunity; 2017 Jun; 50(4):202-210. PubMed ID: 28648105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of biopsy and histochemical analysis in the diagnosis of chronic recurrent parotitis and Sjögren's syndrome].
    Roncević R; Tatić V; Tasić G
    Med Pregl; 1979; 32(5-6):219-21. PubMed ID: 481338
    [No Abstract]   [Full Text] [Related]  

  • 15. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
    Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
    J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Sjögren's reticulated macular dystrophy].
    Buiuc S; Galan S; Anghel K; Veneri E
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(4):767-8. PubMed ID: 3452875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current aspects of Gougerot-Sjõgren syndrome].
    Pisella PJ; Creuzot-Garcher C; Baudouin C
    J Fr Ophtalmol; 1999 Oct; 22(8):889-92. PubMed ID: 10572804
    [No Abstract]   [Full Text] [Related]  

  • 18. Sjogren's syndrome: New paradigms and areas for future research.
    Ambrus JL
    Clin Immunol; 2017 Sep; 182():1-3. PubMed ID: 28673862
    [No Abstract]   [Full Text] [Related]  

  • 19. Varying distribution of acetylation phenotypes in RA patients with and without Sjögren's syndrome.
    Leden I; Hanson A; Melander A; Sturfelt G; Svensson B; Wàhlin-Boll E
    Scand J Rheumatol; 1981; 10(3):253-5. PubMed ID: 7291958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis.
    Iizuka M; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Mod Rheumatol; 2015 Jan; 25(1):158-60. PubMed ID: 24593169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.